| 000 | 01913 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250518090911.0 | ||
| 264 | 0 | _c20200717 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1549-5477 | ||
| 024 | 7 |
_a10.1101/gad.333617.119 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEl-Merahbi, Rabih | |
| 245 | 0 | 0 |
_aThe adrenergic-induced ERK3 pathway drives lipolysis and suppresses energy dissipation. _h[electronic resource] |
| 260 |
_bGenes & development _c04 2020 |
||
| 300 |
_a495-510 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a3T3 Cells |
| 650 | 0 | 4 |
_aAdipose Tissue _xenzymology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aEnergy Metabolism _xgenetics |
| 650 | 0 | 4 |
_aForkhead Box Protein O1 _xmetabolism |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xmetabolism |
| 650 | 0 | 4 |
_aLipase _xgenetics |
| 650 | 0 | 4 |
_aLipolysis _xgenetics |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 6 _xgenetics |
| 650 | 0 | 4 |
_aObesity _xcomplications |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xgenetics |
| 700 | 1 | _aViera, Jonathan Trujillo | |
| 700 | 1 | _aValdes, Angel Loza | |
| 700 | 1 | _aKolczynska, Katarzyna | |
| 700 | 1 | _aReuter, Saskia | |
| 700 | 1 | _aLöffler, Mona C | |
| 700 | 1 | _aErk, Manuela | |
| 700 | 1 | _aAde, Carsten P | |
| 700 | 1 | _aKarwen, Till | |
| 700 | 1 | _aMayer, Alexander E | |
| 700 | 1 | _aEilers, Martin | |
| 700 | 1 | _aSumara, Grzegorz | |
| 773 | 0 |
_tGenes & development _gvol. 34 _gno. 7-8 _gp. 495-510 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1101/gad.333617.119 _zAvailable from publisher's website |
| 999 |
_c30710115 _d30710115 |
||